2021-2026 Database: Sweden Molecular Blood Typing, Grouping and Infectious Disease NAT Screening: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

December 2021 | - | ID: 26A2EA5CFBDFEN
Venture Planning Group

Abstracts

This database from LeadingMarketResearch.com provides the 2021 supplier shares, the 2021-2026 volume and sales forecasts for over 40 tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including:

Blood Typing and Grouping Tests

ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du)

Infectious Disease Screening Tests

AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT

Contents

List Of Tables

LIST OF TABLES

Executive Summary Table: Total Blood Bank Test Volume and Reagent Sales Forecast by Test Category
All Market Segments Blood Typing and Grouping Test Volume Forecast
All Market Segments Infectious Disease Screening Test Volume Forecast
All Market Segments Blood Typing and Grouping Reagent Market Forecast by Major Test
All Market Segments Infectious Disease Screening Reagent Market Forecast by Test
Major Companies Developing or Marketing Blood Typing and Grouping Tests
Major Companies Developing or Marketing HLA Typing Tests
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Blood Bank Analyzers